Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
attention, brought, canceled, chemotherapy, coagulation, conclusively, core, Corticosteroid, divert, Earnout, encountered, eosin, formula, guarantee, hematoxylin, histologic, histology, hsTnI, inability, induction, inflammation, juncture, KCCQ, long, lymphoblastic, lymphoma, manner, mildly, modestly, monogenic, negligible, Neptune, parameter, Questionnaire, Renovacor, reorganization, satisfied, score, specimen, surgical, syndrome, timeframe, transferase, troponin, tumor, upward, vacuolar, waiver
Removed:
announced, break, cellular, Chuvash, compression, constantly, Costa, cranial, decade, density, dosing, East, geographic, healthy, hearing, IMO, Infantile, Malignant, Middle, neurologic, Northern, osteoclast, output, Province, recently, Republic, resorption, Rica, Russia, secondary, small, Sweden, thicker, transmit, Untreated, Vasterbotten, vital
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view